217 related articles for article (PubMed ID: 24979261)
1. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo.
Liu J; Ke F; Xu Z; Liu Z; Zhang L; Yan S; Wang Z; Wang H; Wang H
PLoS One; 2014; 9(6):e101137. PubMed ID: 24979261
[TBL] [Abstract][Full Text] [Related]
2. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
[TBL] [Abstract][Full Text] [Related]
3. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun J; Ding C; Yang Z; Liu T; Zhang X; Zhao C; Wang J
J Transl Med; 2016 Feb; 14():42. PubMed ID: 26856330
[TBL] [Abstract][Full Text] [Related]
5. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
Wang W; Xing C
Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
[TBL] [Abstract][Full Text] [Related]
7. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
[TBL] [Abstract][Full Text] [Related]
8. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
[TBL] [Abstract][Full Text] [Related]
10. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
11. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
12. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.
Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
[No Abstract] [Full Text] [Related]
13. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
15. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer.
Chang H; Wei JW; Tao YL; Ding PR; Xia YF; Gao YH; Xiao WW
Cancer Res Treat; 2018 Oct; 50(4):1203-1213. PubMed ID: 29268566
[TBL] [Abstract][Full Text] [Related]
16. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
Hu J; Li G; Liu L; Wang Y; Li X; Gong J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
[TBL] [Abstract][Full Text] [Related]
17. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
Tao Y; Han T; Zhang T; Sun C
Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
[TBL] [Abstract][Full Text] [Related]
18. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
[TBL] [Abstract][Full Text] [Related]
19. RANKL/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer.
Ouyang J; Hu S; Zhu Q; Li C; Kang T; Xie W; Wang Y; Li Y; Lu Y; Qi J; Xia M; Chen J; Yang Y; Sun Y; Gao T; Ye L; Liang Q; Pan Y; Zhu C
Cell Death Dis; 2024 Jun; 15(6):437. PubMed ID: 38902257
[TBL] [Abstract][Full Text] [Related]
20. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
